Ketosis-prone (Flatbush) diabetes
Diabetes · Endocrine
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
A form of type 2 diabetes (often in people of African or Hispanic origin) that presents acutely with diabetic ketoacidosis but where beta-cell function later recovers, allowing eventual withdrawal of insulin. Managed acutely as DKA but with a different long-term trajectory.
Red flags
- Severe acidosis or haemodynamic instability (as any DKA)
- Recurrent DKA episodes
- Failure of expected beta-cell recovery (reconsider type 1)
Assessment
Differential diagnosis
- Type 1 diabetes with autoimmune markers
- Classic type 2 diabetes with intercurrent illness
- Latent autoimmune diabetes of adults
- Pancreatic (secondary) diabetes
- Euglycaemic DKA (SGLT2 inhibitor)
Investigations
- Glucose, ketones, blood gas (diagnose DKA)
- Islet autoantibodies (GAD, IA-2) - typically negative
- C-peptide (to assess residual beta-cell function, often after recovery)
- HbA1c
- Standard DKA monitoring bloods
Management
- Treat the acute presentation exactly as diabetic ketoacidosis (fluids, fixed-rate insulin, potassium, monitoring)
- Send autoantibodies and plan C-peptide assessment to characterise the diabetes type
- Continue insulin initially after resolution
- Reassess beta-cell function over the following weeks/months
- In antibody-negative patients with recovering function, cautiously transition toward oral agents under specialist guidance
- Educate on ketone monitoring and sick-day rules
Drugs & doses
Acute DKA management: IV fluids, fixed-rate insulin infusion, potassium replacement
Basal-bolus insulin after recovery initially
Later transition to oral hypoglycaemics (e.g. metformin) if beta-cell function recovers
Follow standard DKA protocol
Disposition
Admit and treat as DKA; endocrine follow-up to reclassify and adjust therapy.
Complications & pitfalls
- Recurrent ketoacidosis
- Misclassification of diabetes type and inappropriate long-term therapy
- Standard DKA complications
Exam pearls
- Antibody-negative DKA in an adult of African/Hispanic origin may be ketosis-prone type 2 diabetes - beta-cell function can recover
- C-peptide measured after recovery helps decide who can come off insulin
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.